Terms: = Prostate cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Treatment
32 results:
1. The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of prostate cancer.
Salamini-Montemurri M; Vizoso-Vázquez Á; Barreiro-Alonso A; Lorenzo-Catoira L; Rodríguez-Belmonte E; Cerdán ME; Lamas-Maceiras M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542079
[TBL] [Abstract] [Full Text] [Related]
2. Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis.
Wang X; Wu Y; Liu J; Xu X; Sheng Z; Liu W; Chen M; Ma Y; Zhao D; Li D; Zheng X
Toxicol Appl Pharmacol; 2022 Oct; 452():116169. PubMed ID: 35926565
[TBL] [Abstract] [Full Text] [Related]
3. A Highly Specific Multiple Enhancement Theranostic Nanoprobe for PET/MRI/pai Image-Guided Radioisotope Combined Photothermal Therapy in prostate cancer.
Xia L; Meng X; Wen L; Zhou N; Liu T; Xu X; Wang F; Cheng Z; Yang Z; Zhu H
Small; 2021 May; 17(21):e2100378. PubMed ID: 33870644
[TBL] [Abstract] [Full Text] [Related]
4. Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates serpine1 Expression Reducing Migration in prostate cancer Cells.
Mao Y; Li W; Hua B; Gu X; Pan W; Chen Q; Xu B; Wang Z; Lu C
Biomed Res Int; 2020; 2020():2406159. PubMed ID: 32104682
[TBL] [Abstract] [Full Text] [Related]
5. Photoirradiation after aminolevulinic acid treatment suppresses cancer cell proliferation through the HO-1/p21 pathway.
Nakayama T; Kobayashi T; Shimpei O; Fukuhara H; Namikawa T; Inoue K; Hanazaki K; Takahashi K; Nakajima M; Tanaka T; Ogura SI
Photodiagnosis Photodyn Ther; 2019 Dec; 28():10-17. PubMed ID: 31404677
[TBL] [Abstract] [Full Text] [Related]
6. Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck cancer.
Rich LJ; Miller A; Singh AK; Seshadri M
Theranostics; 2018; 8(8):2064-2078. PubMed ID: 29721063
[TBL] [Abstract] [Full Text] [Related]
7. Aspirin Inhibits IKK-β-mediated prostate cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
[TBL] [Abstract] [Full Text] [Related]
8. MnTE-2-PyP modulates thiol oxidation in a hydrogen peroxide-mediated manner in a human prostate cancer cell.
Tong Q; Zhu Y; Galaske JW; Kosmacek EA; Chatterjee A; Dickinson BC; Oberley-Deegan RE
Free Radic Biol Med; 2016 Dec; 101():32-43. PubMed ID: 27671770
[TBL] [Abstract] [Full Text] [Related]
9. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
[TBL] [Abstract] [Full Text] [Related]
10. MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the pai-1 gene.
Tong Q; Weaver MR; Kosmacek EA; O'Connor BP; Harmacek L; Venkataraman S; Oberley-Deegan RE
Free Radic Biol Med; 2016 May; 94():185-94. PubMed ID: 26944191
[TBL] [Abstract] [Full Text] [Related]
11. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
[TBL] [Abstract] [Full Text] [Related]
12. Deciphering the systems biology of mTOR inhibition by integrative transcriptome analysis.
Domhan S; Schwager C; Wei Q; Muschal S; Sommerer C; Morath C; Wick W; Maercker C; Debus J; Zeier M; Huber PE; Abdollahi A
Curr Pharm Des; 2014; 20(1):88-100. PubMed ID: 23530502
[TBL] [Abstract] [Full Text] [Related]
13. Predicting pubic arch interference in prostate brachytherapy on transrectal ultrasonography-computed tomography fusion images.
Fukada J; Shigematsu N; Nakashima J; Ohashi T; Kawaguchi O; Oya M
J Radiat Res; 2012 Sep; 53(5):753-9. PubMed ID: 22843359
[TBL] [Abstract] [Full Text] [Related]
14. Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.
Guo Z; He Y; Wang S; Zhang A; Zhao P; Gao C; Cao B
Oncol Rep; 2011 Aug; 26(2):511-7. PubMed ID: 21567096
[TBL] [Abstract] [Full Text] [Related]
15. Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity.
Huang KT; Walker AM
Prostate; 2010 Jan; 70(1):37-47. PubMed ID: 19739126
[TBL] [Abstract] [Full Text] [Related]
16. Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
Svatek RS; Jeldres C; Karakiewicz PI; Suardi N; Walz J; Roehrborn CG; Montorsi F; Slawin KM; Shariat SF
Prostate; 2009 Jun; 69(8):886-94. PubMed ID: 19229851
[TBL] [Abstract] [Full Text] [Related]
17. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
[TBL] [Abstract] [Full Text] [Related]
18. The effect of short-term estradiol therapy on clotting and inflammatory markers in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Luthra P; Fall PM; Dauser D
Aging Male; 2008 Jun; 11(2):71-5. PubMed ID: 18570058
[TBL] [Abstract] [Full Text] [Related]
19. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.
Smith MR; Lee H; Fallon MA; Nathan DM
Urology; 2008 Feb; 71(2):318-22. PubMed ID: 18308111
[TBL] [Abstract] [Full Text] [Related]
20. Short term effects of GnRH agonists on plasma fibrinolytic balance in patients with advanced prostate cancer.
Agirbasli M; Baykan OA; Tekin A; Sengor F; Cincin AA; Demir M; Vaughan DE
J Thromb Thrombolysis; 2009 Feb; 27(2):172-4. PubMed ID: 18183354
[TBL] [Abstract] [Full Text] [Related]
[Next]